PHX 2.17% 4.7¢ pharmx technologies limited

Ann: Appendix 4C - quarterly , page-2

  1. 2,481 Posts.
    lightbulb Created with Sketch. 173
    Fantastic to see the repayments made out of cash flow and now Corum can concentrate on being the best service provider in their business areas.

    On the Pharmacy front the demands on them for first class hardware/software and conectivity to service all the new government's "E-Health" plans guanantee substantial growth in this sector for the providers and Corum are at the forefront as one of the leaders.

    The next quarters financials will be a "watershed" result and only an indication of better things to come.

    My greatest fear for Corum is that there will be a preditor in the Medical Information Technology Services field that will see Corum as an opportunity because of obvious synergies....the other main player in pharmacy is too tightly controlled to be a target!
 
watchlist Created with Sketch. Add PHX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.